Dependence of cancer risk from environmental exposures on underlying genetic susceptibility: an illustration with polycyclic aromatic hydrocarbons and breast cancer
Couplée aux données d'une étude cas-témoins américaine, cette étude prospective évalue l'association entre le niveau d'hydrocarbures aromatiques polycycliques contenus dans le sang et le risque absolu de cancer du sein à 10 ans en prenant en compte les antécédents familiaux de cancer (80 cas, 156 témoins)
Background: Most studies of environmental risk factors and breast cancer are conducted using average risk cohorts. Methods: We examined the association between polycyclic aromatic hydrocarbon (PAH)-albumin adducts in bloods from baseline and breast cancer risk in a prospective nested case–control study (New York site of the BCFR, 80 cases and 156 controls). We estimated the 10-year absolute breast cancer risk by a risk model that uses pedigree information (BOADICEA) and evaluated whether the increased risk from PAH differed by absolute risk. Results: Women with detectable levels of PAH had a twofold association with breast cancer risk (odds ratio (OR)=2.04; 95% CI=1.06–3.93) relative to women with non-detectable levels. The association increased with higher levels of PAH (greater than or equal tomedian) and by a higher level of absolute breast cancer risk (10-year risk greater than or equal to3.4%: OR=4.09, 95% CI=1.38–12.13). Conclusions: These results support that family-based cohorts can be an efficient way to examine gene–environment interactions